Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study

PURPOSE: This study evaluated the real-world tolerability and treatment effectiveness of BIC/FTC/TAF in treatment-experienced patients living with HIV-1 in Taiwan, especially in those with viremia at switch. PATIENTS AND METHODS: This was a retrospective cohort study of adult patients in Taiwan with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hui-Min, Chou, Pei-Yun, Chou, Chen-Hsi, Tsai, Hung-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628065/
https://www.ncbi.nlm.nih.gov/pubmed/34853517
http://dx.doi.org/10.2147/IDR.S331647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628065/
https://www.ncbi.nlm.nih.gov/pubmed/34853517
http://dx.doi.org/10.2147/IDR.S331647

Ejemplares similares